(Q24188224)

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotic supplementation reduces the duration and incidence of infections but not severity in elite rugby union players

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Human bocavirus in the nasopharynx of otitis-prone children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotic effects on cold and influenza-like symptom incidence and duration in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotics for treating persistent diarrhoea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Bacterial probiotic modulation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Diagnosis and treatment of upper respiratory tract infections in the primary care setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Stimulation of the Immune System by Lactic Cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Clinical significance and pathogenesis of viral respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Saline nasal irrigation for acute upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotics for preventing preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Immune System Stimulation by Probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

New scientific paradigms for probiotics and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Changing use of antibiotics in community-based outpatient practice, 1991-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Immunologic function in the elderly after injury--the neutrophil and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Immunological deficiency in "otitis-prone" children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotics for preventing acute upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotics for preventing acute upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

Treatment of acute otitis media with probiotics in otitis-prone children—A double-blind, placebo-controlled randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Immunogenic yeast-based fermentate for cold/flu-like symptoms in nonvaccinated individuals

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Immunologic effects of yogurt

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

A new chance of preventing winter diseases by the administration of synbiotic formulations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Randomized controlled trial of probiotics to reduce common cold in schoolchildren

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

High-intensity training reduces CD8+ T-cell redistribution in response to exercise

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006895.PUB3

7 January 2021

10.1002/14651858.CD006895.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25927096

1 reference

Consolidated OpenCitations Corpus – April 2017